Skip to main content

Table 3 Correlation of subjective well-being and drug attitude with symptomatology and global functioning. Spearman rank correlation

From: Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication

    PANSS
positive
PANSS
negative
PANSS
general
PANSS
total
GAF DAI
total
Week 2 SWN-K total r Spearman (p-value) −.274 (.143) −.323 (.082) −.419* (.021) −.375* (.041) .559** (.001) .196 (.299)
  DAI total r Spearman (p-value) −.017 (.93) −.095 (.616) −.206 (.276) −.197 (.297) −.006 (.976) -
Week 4 SWN-K total r Spearman (p-value) −.415* (.022) −.235 (.210) −.441* (.015) −.480** (.007) .642** (.000) .128 (.5)
  DAI total r Spearman (p-value) .084 (.66) .161 (.394) .09 (.637) .19 (.314) −.203 (.283) -
Week 12 SWN-K total r Spearman (p-value) −.238 (.205) −.238 (.206) −.324 (.081) −.318 (.087) .576** (.001)a .068 (.727)a
  DAI total r Spearman (p-value) −.069 (.721)a −.102 (.598)a −.095 (.625)a −.114 (.555)a −.095 (.63)b -
  1. SWN-K = Subjective Well-being under Neuroleptic Treatment Scale, short form; PANSS = Positive and Negative Syndrome Scale; DAI = Drug Attitude Inventory
  2. aN = 29
  3. bN = 28